The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
F 2 -Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
Abstract
Oxidative stress is implicated as one of the major underlying mechanisms behind many acute and chronic diseases, and involved in normal aging. However, the measurement of free radicals or their end products is complicated. Thus, proof of association of free radicals in pathologic conditions has been absent. Isoprostanes are prostaglandin-like bioactive compounds that are biosynthesized in vivo independent of cyclooxygenases, principally through free-radical catalyzation of arachidonic acid. Isoprostanes are now considered to be reliable biomarkers of oxidative stress, as evidenced by an autonomous study organized recently by the National Institutes of Health (NIH) in the United States. A number of these compounds have potent biologic activities such as vasoconstrictive and certain inflammatory properties. Isoprostanes are involved in many human diseases. Additionally, elevated levels of F(2)-isoprostanes have been seen in normal human pregnancy and after intake of some fatty acids, but their physiologic assignments have not yet been distinctive. This evidence indicates that measurement of bioactive F(2)-isoprostanes in body fluids offers a unique noninvasive analytic utensil to study the role of free radicals in physiology, oxidative stress-related diseases, experimental acute or chronic inflammatory conditions, and also in the assessment of various antioxidants, radical scavengers, and drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–236 of 236
Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia
Harsem, N. K., Brække, K., & Staff, A. C. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.11.014 · Cited by 58
Mehrabi, M. R. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00108-x · Cited by 58
Raal, F. J., Pilcher, G. J., Waisberg, R., Buthelezi, E. P., Veller, M., & Joffe, B. I. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00095-8 · Cited by 57
Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans
Lin, C., Hsu, Y.-T., Lin, T.-K., Morrow, J. D., Hsu, J., Hsu, Y.-H., Hsieh, T.-C., Tsay, P., & Yen, H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.019 · Cited by 56
Tholstrup, T., Hellgren, L. I., Petersen, M., Basu, S., Straarup, E. M., Schnohr, P., & Sandström, B. (2004) · Journal of Nutrition · doi:10.1093/jn/134.5.1051 · Cited by 55
Self-citationSodergren, E., Gustafsson, I. B., Basu, S., Nourooz‐Zadeh, J., Nälsén, C., Turpeinen, A. M., Berglund, L., & Vessby, B. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601246 · Cited by 54
Self-citationDunstan, J. A., Breckler, L., Hale, J., et al. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02657.x · Cited by 52
Smith, K. S., Lee, C., Ridlington, J. W., Leonard, S. W., Devaraj, S., & Traber, M. G. (2003) · Lipids · doi:10.1007/s11745-003-1130-9 · Cited by 51
Kaikkonen, J., Porkkala-Sarataho, E., Morrow, J. D., Roberts, L. J., Nyyssönen, K., Salonen, R. M., Tuomainen, T., Ristonmaa, U., Poulsen, H. E., & Salonen, J. T. (2001) · Free Radical Research · doi:10.1080/10715760100301461 · Cited by 50
Helmersson, J., & Basu, S. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0295 · Cited by 49
Self-citationSuarna, C., Wu, B. J., Choy, K. J., Mori, T. A., Croft, K. D., Cynshi, O., & Stocker, R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.013 · Cited by 49
Wagner, R., Weare, C., Jin, N., Mohler, E. R., & Rhoades, R. A. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00127-5 · Cited by 48
Increased urinary F2-isoprostanes in patients with Crohn's disease
Cracowski, J., Bonaz, B. L., Bessard, G., Bessard, J., Anglade, C., & Fournet, J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05427.x · Cited by 45
Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model
Hasty, A. H., Gruen, M. L., Terry, E. S., Surmi, B. K., Atkinson, R. D., Gao, L., & Morrow, J. D. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.03.012 · Cited by 45
Generation of the Isoprostane 8-Epi-prostaglandin F2α In Vitro and In Vivo via the Cyclooxygenases
Klein, T., Reutter, F., Schweer, H., Seyberth, H. W., & Nüsing, R. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36968-x · Cited by 43
Burke, A., Lawson, J. A., Meagher, E. A., Rokach, J., & FitzGerald, G. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2499 · Cited by 42
Wigg, S. J., Tare, M., Forbes, J. M., Cooper, M. E., Thomas, M. C., Coleman, H. A., Parkington, H. C., & O’Brien, R. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1411-x · Cited by 41
Mutschler, D., Eriksson, M. B., Wikström, B. G., Lind, L., Larsson, A., Bergren-Kiiski, R., Lagrange, A., Nordgren, A., & Basu, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000075740.61294.a6 · Cited by 40
Self-citationWohlin, M., Helmersson, J., Sundström, J., Ärnlöv, J., Vessby, B., Larsson, A. O., Andrén, B., Lind, L., & Basu, S. (2007) · Cytokine · doi:10.1016/j.cyto.2007.05.014 · Cited by 40
Self-citationPassive cigarette smoking increases isoprostane formation
Ahmadzadehfar, H., Oguogho, A., Efthimiou, Y., Kritz, H., & Sinzinger, H. F. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.099 · Cited by 40
Berg, K., Wiseth, R., Bjerve, K. S., Brurok, H., Gunnes, S., Skarra, S., Jynge, P., & Basu, S. (2004) · Free Radical Research · doi:10.1080/10715760410001688339 · Cited by 37
Self-citationMattsson, N., Haghighi, S., Andersen, O., Yao, Y., Rosengren, L., Blennow, K., Praticò, D., & Zetterberg, H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.044 · Cited by 36
A prospective analysis of oxidative stress and liver transplantation1
Burke, A., FitzGerald, G. A., & Lucey, M. R. (2002) · Transplantation · doi:10.1097/00007890-200207270-00012 · Cited by 36
Murai, Y., Hishinuma, T., Suzuki, N., Satoh, J., Toyota, T., & Mizugaki, M. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00061-7 · Cited by 30
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target
Basu, S. (2007) · Food & Nutrition Research · doi:10.3402/fnr.v51i2.1611 · Cited by 28
Self-citationRadioimmunological measurement of F2-isoprostanes after hydrolysis of lipids in tissues
Södergren, E., Vessby, B., & Basu, S. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0172 · Cited by 27
Self-citationLiu, X. L., Nozari, A., Basu, S., Ronquist, G. K., Rubertsson, S., & Wiklund, L. (2002) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2002.460511.x · Cited by 27
Self-citationMonga, M., Dunn, K., & Rajasekaran, M. “. (2001) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2001.11753554 · Cited by 20
Mayne, S. T., Walter, M. F., Cartmel, B., Goodwin, W. J., & Blumberg, J. B. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4901_1 · Cited by 18
Camphausen, K. A., Ménard, C. M., Sproull, M. T., Goley, E., Basu, S., & Coleman, C. N. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01937-0 · Cited by 17
Self-citationF2-Isoprostanes in Kidney Transplant Patients: Relationship With Inflammatory Markers
Lauzurica, R., Pastor, M. C., Bayés, B., Hernández, J., Bonet, J., Llopis, M. A., Carrera, L. B., & Romero, R. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.09.106 · Cited by 17
F2-isoprostane induced prostaglandin formation in the rabbit
Basu, S. (2006) · Free Radical Research · doi:10.1080/10715760500511492 · Cited by 16
Self-citationFormation of Isoprostanes in Children with Type IIa Hypercholesterolemia
Cracowski, J., Ploin, D., Bessard, J., Baguet, J.-P., Stanke‐Labesque, F., Mallion, J.-M., Bost, M., & Bessard, G. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200108000-00008 · Cited by 12
An Improved GC/MS-Based Procedure for the Quantitation of the Isoprostane 15-F2t -IsoP in Rat Plasma
Parker, C. E., Graham, L., Nguyen, M.-N., et al. (2001) · Molecular Biotechnology · doi:10.1385/mb:18:2:105 · Cited by 11
Sarabi, M., Vessby, B. O., Basu, S., Millgård, J., & Lind, L. (1999) · Journal of Vascular Research · doi:10.1159/000025691 · Cited by 9
Self-citation(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Lipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,006
Assessment of antioxidant capacity in vitro and in vivo
Niki, E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.016 · Cited by 873
Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers
Giustarini, D., Dalle-Donne, I., Tsikas, D., & Rossi, R. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408360903142326 · Cited by 440
Hollman, P. C. H., Cassidy, A., Comte, B., Heinonen, M., Richelle, M., Richling, E., Serafini, M., Scalbert, A., Sies, H., & Vidry, S. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.131490 · Cited by 406
Nakatomi, Y., Mizuno, K., Ishii, A., Wada, Y., Tanaka, M., Tazawa, S., Onoe, K., Fukuda, S., Kawabe, J., Takahashi, K., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131045 · Cited by 365
Metadata
- Authors
- Basu, S.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2008-08
- Volume
- 10
- Issue
- 8
- Pages
- 1405-1434
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1996922652
- Cited by
- 268
- References
- 236
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.